secwatch.observer — SEC 8-K summary
======================================

Issuer:     NEUROONE MEDICAL TECHNOLOGIES Corp (NMTC)
CIK:        0001500198
Form:       8-K
Filed at:   2025-12-22T23:59:59+00:00
Accession:  0001213900-25-124165
Event type: leadership
Sentiment:  positive
Materiality: 0.55
Item codes: 5.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

NeuroOne appoints Jason Mills, Penumbra EVP of Strategy, to Board of Directors
------------------------------------------------------------------------------

- Board size increased to five; Mills appointed as Class I director effective Dec 18, 2025.
- Mills will serve on Compensation and Nominating & Corporate Governance Committees.
- Mills is EVP of Strategy at Penumbra (PEN), a leading thrombectomy company.
- Previously Managing Director and head of med-tech research at Canaccord Genuity for 13+ years.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1500198/000121390025124165/0001213900-25-124165-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1500198/000121390025124165/ea0270439-8k_neuroone.htm
  HTML page:      https://secwatch.observer/filing/0001213900-25-124165

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer